Related Experiment Video
Updated: Jul 18, 2025

Flow Cytometric Analysis of Extracellular Vesicles from Cell-conditioned Media
Published on: February 12, 2019
Extracellular Vesicles and Cardiac Aging
Fernando A C Seara1,2, Leonardo Maciel1,3, Tais Hanae Kasai-Brunswick1,4
1Carlos Chagas Filho Institute of Biophysics, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil.
Insights
Aging populations face health challenges, especially cardiovascular disease. Senescent cells release extracellular vesicles (EVs) that contribute to heart aging, but stem cell EVs may offer anti-aging therapies.
Area of Science:
- Cardiovascular Science
- Gerontology
- Cell Biology
Background:
- Global population aging presents significant health and socioeconomic challenges.
- Cardiovascular disease is the leading cause of mortality in the elderly.
- Accumulation of cardiac senescent cells and their secreted factors contribute to age-related cardiovascular decline.
Purpose of the Study:
- To investigate the role of senescent cells and their secreted extracellular vesicles (EVs) in cardiovascular aging.
- To explore the potential of EVs as biomarkers for aging-related conditions.
- To examine the therapeutic potential of stem and progenitor cell-derived EVs for anti-aging strategies.
Main Methods:
- Analysis of senescence-associated secretory phenotype (SASP) compounds released by senescent cells.
- Characterization of extracellular vesicles (EVs) secreted by senescent cells.
- Investigation of EV uptake by recipient cells and their effects on cellular function and extracellular matrix.
- Exploration of EVs from stem and progenitor cells for potential rejuvenating effects.
Main Results:
- Senescent cells release EVs containing SASP factors and damaged molecules.
- These EVs can be internalized by neighboring cells, causing damage and promoting fibrosis and vascular calcification.
- The molecular signature of aging-related EVs is variable, suggesting biomarker potential.
- EVs from stem and progenitor cells may possess rejuvenating properties.
Conclusions:
- Senescent cell-derived EVs play a critical role in age-related cardiovascular dysfunction.
- EVs represent a potential source for novel aging biomarkers.
- Stem and progenitor cell-derived EVs hold promise for future anti-aging therapies.
Abstract:
Global population aging is a major challenge to health and socioeconomic policies. The prevalence of diseases progressively increases with aging, with cardiovascular disease being the major cause of mortality among elderly people. The allostatic overload imposed by the accumulation of cardiac senescent cells has been suggested to play a pivotal role in the aging-related deterioration of cardiovascular function. Senescent cells exhibit intrinsic disorders and release a senescence-associated secretory phenotype (SASP). Most of these SASP compounds and damaged molecules are released from senescent cells by extracellular vesicles (EVs). Once secreted, these EVs can be readily incorporated by recipient neighboring cells and elicit cellular damage or otherwise can promote extracellular matrix remodeling. This has been associated with the development of cardiac dysfunction, fibrosis, and vascular calcification, among others. The molecular signature of these EVs is highly variable and might provide important information for the development of aging-related biomarkers. Conversely, EVs released by the stem and progenitor cells can exert a rejuvenating effect, raising the possibility of future anti-aging therapies.
More Related Videos
08:13Purification and Transplantation of Myogenic Progenitor Cell Derived Exosomes to Improve Cardiac Function in Duchenne Muscular Dystrophic Mice
Published on: April 10, 2019
11:53Simultaneous Isolation and Culture of Atrial Myocytes, Ventricular Myocytes, and Non-Myocytes from an Adult Mouse Heart
Published on: June 14, 2020
Related Concept Videos
Overview of Exosomes
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
Heart Failure II: Pathophysiology
Pathophysiology of Heart Failure
Overview of Secretory Vesicles
Various proteins regulate the aggregation of molecules inside the secretory vesicles. Chromogranins...